APLM Apollomics, Inc. Yalpi rentabellik

Apollomics, Inc. (APLM) kompaniyasining rasmiy ramzlari

Apollomics, Inc. (APLM) olingan orfan statuslaridan foydalangan holda onkologiya dasturlarini muvaffaqiyatli rivojlantirayotgan barqaror boshqaruvni saqlab qolmoqda. Kompaniya o'pka va jigar o'smalari uchun shaxsiylashtirilgan davolash tizimini ishlab chiqmoqda. Tushumning yalpi foyda marjasi ulushi xarajatlar samaradorligini ko'rsatadi va oxirgi ko'rsatkich 0.00 ni tashkil etadi. Bu yangi segmentlarni egallash uchun webreltinibning Xitoy va AQSh bozorlaridagi mavjudligini global miqyosda kengaytirish strategiyasini tasdiqlaydi.

Yalpi rentabellik: Apollomics Corp (APLM) 21.02.2024 - 19.11.2026 uchun

Apollomics Corp (APLM) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Kompaniyaning asosiy tahlili:APLM - Apollomics
Apollomics Inc. seriyali mahsuloti

Apollomics, Inc. o'zining onkologik dori vositalarini bozorga chiqarishga tayyorgarlik ko'rayotgan bir paytda, sherikliklar orqali joriy pul oqimini shakllantirmoqda. Valo kredit marjasi bevosita ishlab chiqarish xarajatlaridan keyin qolgan daromad qismini o'lchash orqali ushbu modelning samaradorligini aniqlaydi, bu esa investorlarga yalpi foyda marjasi dinamikasi orqali har bir mahsulot birligining fundamental daromadliligini baholash imkonini beradi.

Muhim raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|AURA (Aura Biosciences Inc) - Yalpi marja|Yalpi foyda marjasi candeltx.com CADL|Yalpi marja ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Yalpi foyda normasi|Yalpi rentabellik Actuate Therapeutics, Inc. ACTU|citiusonc.com - Yalpi rentabellik|TuHURA Biosciences Inc. - Yalpi marja|TARA - Yalpi marja|FATE (Fate Therapeutics) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha rentabellik Aadi Bioscience, Inc.|Yalpi foyda bo'yicha rentabellik TCRX|Yalpi rentabellik CSBR|Yalpi marja XBIT|Yalpi foyda bo'yicha sotuv rentabelligi CEL-SCI Corp.|Yalpi rentabellik ostherapies.com OSTX|RADX: Sotuvning yalpi rentabelligi|ARTV: Yalpi foyda bo'yicha rentabellik|ANL (Adlai Nortye) - Sotuvning yalpi rentabelligi|Veru (VERU) - Yalpi rentabellik|Yalpi foyda bo'yicha rentabellik Tempest Therapeutics Inc|Yalpi rentabellik Xilio Therapeutics|Sotuvning yalpi rentabelligi RENB (Renovaro Inc.)|Yalpi rentabellik Mural Oncology PLC (MURA)|Yalpi marja Kairos Pharma (KAPA)|Yalpi rentabellik onkuretherapeutics.com OKUR|GDTC: Sotuvning yalpi rentabelligi|CRIS: Yalpi foyda bo'yicha rentabellik|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik